Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury

Cardiovascular Research

Volumn 94, Issue 2, 2012, Pages 359-369

  Ussher, John R ^a   Wang, Wei ^a   Gandhi, Manoj ^a   Keung, Wendy ^a   Samokhvalov, Victor ^a   Oka, Tatsujiro ^a   Wagg, Cory S ^a   Jaswal, Jagdip S ^a   Harris, Robert A ^b   Clanachan, Alexander S ^a   Dyck, Jason R B ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myocardial infarction; Glucose oxidation; Ischaemia reperfusion; Malonyl CoA decarboxylase; Pyruvate dehydrogenase

Indexed keywords

DICHLOROACETIC ACID; FATTY ACID; MALONYL COENZYME A DECARBOXYLASE; PYRUVATE DEHYDROGENASE;

ACUTE HEART INFARCTION; AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUCOSE OXIDATION; GLYCOLYSIS; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SYSTOLIC BLOOD PRESSURE; WILD TYPE;

ANIMALS; CARBOXY-LYASES; CARDIOTONIC AGENTS; GLUCOSE; MALONYL COENZYME A; MICE; MICE, INBRED STRAINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROTEIN-SERINE-THREONINE KINASES;

EID: 84860134902     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs129     Document Type: Article

References (53)

1. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999;79:609-634. (Pubitemid 29210931)
2. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 2002;39:718-725. (Pubitemid 34158171)
3. Ussher JR, Lopaschuk GD. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc Res 2008;79:259-268. (Pubitemid 351951618)
4. Ussher JR, Koves TR, Jaswal JS, Zhang L, Ilkayeva O, Dyck JR et al. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes 2009;58:1766-1775.
5. Ussher JR, Lopaschuk GD. Clinical implications of energetic problems in cardiovascular disease. Heart Metab 2006;32:9-17.
6. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 1990;66:546-553. (Pubitemid 20041185)
7. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 1991;266: 8162-8170. (Pubitemid 21906491)
8. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 1996;79:940-948. (Pubitemid 26359235)
9. Jaswal JS, Ussher JR, Lopaschuk GD. Myocardial fatty acid utilization as a determinant of cardiac efficiency and function. Clinical Lipidol 2009;4:379-389.
10. Hafstad AD, Khalid AM, How OJ, Larsen TS, Aasum E. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice. Am J Physiol Endocrinol Metab 2007;292:E1288-E1294. (Pubitemid 46684596)
11. Dyck JR, Cheng JF, Stanley WC, Barr R, Chandler MP, Brown S et al. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ Res 2004;94:e78-e84.
12. Dyck JR, Hopkins TA, Bonnet S, Michelakis ED, Young ME, Watanabe M et al. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation 2006;114: 1721-1728. (Pubitemid 44607120)
13. Lopaschuk GD, Barr R, Thomas PD, Dyck JR. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase. Circ Res 2003;93: e33-e37.
14. Goodwin GW, Taegtmeyer H. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. Am J Physiol 1999;277:E772-E777. (Pubitemid 29522631)
15. Ussher JR, Lopaschuk GD. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion. Basic Res Cardiol 2009;104:203-210.
16. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997;244:1-14. (Pubitemid 27079689)
17. Jeoung NH, Wu P, Joshi MA, Jaskiewicz J, Bock CB, Depaoli-Roach AA et al. Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation. Biochem J 2006;397:417-425. (Pubitemid 44187500)
18. Barr RL, Lopaschuk GD. Direct measurement of energy metabolism in the isolated working rat heart. J Pharmacol Toxicol Methods 1997;38:11-17. (Pubitemid 27460595)
19. Larsen TS, Belke DD, Sas R, Giles WR, Severson DL, Lopaschuk GD et al. The isolated working mouse heart: methodological considerations. Pflugers Arch 1999;437:979-985. (Pubitemid 29210517)
20. Liu B, el Alaoui-Talibi Z, Clanachan AS, Schulz R, Lopaschuk GD. Uncoupling of contractile function from mitochondrial TCA cycle activity and MVO2 during reperfusion of ischemic hearts. Am J Physiol 1996;270:H72-H80.
21. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994; 1213:263-276. (Pubitemid 24262910)
22. Soltys CL, Kovacic S, Dyck JR. Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity. Am J Physiol Heart Circ Physiol 2006;290:H2472-H2479. (Pubitemid 43846078)
23. Ussher JR, Jaswal JS, Wagg CS, Armstrong HE, Lopaschuk DG, Keung Wet al. Role of the atypical protein kinase Czeta in regulation of 5′-AMP- activated protein kinase in cardiac and skeletal muscle. Am J Physiol Endocrinol Metab 2009;297:E349-E357.
24. Niu W, Huang C, Nawaz Z, Levy M, Somwar R, Li D et al. Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. J Biol Chem 2003;278: 17953-17962. (Pubitemid 36799402)
25. Constantin-Teodosiu D, Cederblad G, Hultman E. A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue. Anal Biochem 1991;198: 347-351.
26. King MT, Reiss PD, Cornell NW. Determination of short-chain coenzyme A compounds by reversed-phase high-performance liquid chromatography. Methods Enzymol 1988;166:70-79. (Pubitemid 19048579)
27. Sarzanini C, Bruzzoniti MC, Mentasti E. Preconcentration and separation of haloacetic acids by ion chromatography. J Chromatogr A 1999;850:197-211. (Pubitemid 29327218)
28. Stacpoole PW, Henderson GN, Yan Z, Cornett R, James MO. Pharmacokinetics, metabolism and toxicology of dichloroacetate. Drug Metab Rev 1998;30:499-539.
29. Jeoung NH, Harris RA. Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008;295:E46-E54.
30. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 1993;268:25836-25845. (Pubitemid 23358202)
31. Arslan F, de Kleijn DP, Pasterkamp G. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 2011;8:292-300.
32. Opie LH. Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia. Circulation 2008;117:2172-2177.
33. Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev 2005;4:CD003614.
34. Stanley WC. Partial fatty acid oxidation inhibitors for stable angina. Expert Opin Investig Drugs 2002;11:615-629. (Pubitemid 34520613)
35. Clarke B, Spedding M, Patmore L, McCormack JG. Protective effects of ranolazine in guinea-pig hearts during low-flow ischaemia and their association with increases in active pyruvate dehydrogenase. Br J Pharmacol 1993;109:748-750. (Pubitemid 23181056)
36. Dyck JR, Lopaschuk GD. Malonyl CoA control of fatty acid oxidation in the ischemic heart. J Mol Cell Cardiol 2002;34:1099-1109. (Pubitemid 35205154)
37. Clanachan AS. Contribution of protons to post-ischemic Na(+) and Ca(2+) overload and left ventricular mechanical dysfunction. J Cardiovasc Electrophysiol 2006; 17(Suppl 1):S141-S148.
38. Jeremy RW, Ambrosio G, Pike MM, Jacobus WE, Becker LC. The functional recovery of post-ischemic myocardium requires glycolysis during early reperfusion. J Mol Cell Cardiol 1993;25:261-276. (Pubitemid 23154948)
39. Nakamura K, Kusuoka H, Ambrosio G, Becker LC. Glycolysis is necessary to preserve myocardial Ca2+ homeostasis during beta-adrenergic stimulation. Am J Physiol 1993; 264:H670-H678. (Pubitemid 23109854)
40. Imahashi K, Pott C, Goldhaber JI, Steenbergen C, Philipson KD, Murphy E. Cardiacspecific ablation of the Na+-Ca2+ exchanger confers protection against ischemia/reperfusion injury. Circ Res 2005;97:916-921. (Pubitemid 41552677)
41. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007;13:332-339. (Pubitemid 46376688)
42. Lionetti V, Linke A, Chandler MP, Young ME, Penn MS, Gupte S et al. Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure. Cardiovasc Res 2005;66:454-461. (Pubitemid 40725757)
43. Gao XM, Liu Y, White D, Su Y, Drew BG, Bruce CR et al. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol 2011;50:991-999.
44. Haudek SB, Taffet GE, Schneider MD, Mann DL. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 2007;117:2692-2701. (Pubitemid 47494369)
45. Lopaschuk GD, Ussher JR, Jaswal JS. Targeting intermediary metabolism in the hypothalamus as a mechanism to regulate appetite. Pharmacol Rev 2010;62:237-264.
46. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007;87:507-520. (Pubitemid 47084679)
47. Finck BN, Bernal-Mizrachi C, Han DH, Coleman T, Sambandam N, LaRiviere LL et al. A potential link between muscle peroxisome proliferator-activated receptor-alpha signaling and obesity-related diabetes. Cell Metab 2005;1:133-144. (Pubitemid 43960595)
48. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56.
49. Savage DB, Choi CS, Samuel VT, Liu ZX, Zhang D, Wang A et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Investig 2006;116: 817-824. (Pubitemid 43326891)
50. Zhang D, Liu ZX, Choi CS, Tian L, Kibbey R, Dong J et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci USA 2007;104:17075-17080. (Pubitemid 350210994)
51. An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 2004;10:268-274. (Pubitemid 38667617)
52. Haessler R, Davis RF, Wolff RA, Kozume K, Shangraw R, Van Winkle DM. Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium. Shock 1996;5:66-71. (Pubitemid 126729536)
53. Gozal Y, Wolff RA, Van Winkle DM. Manipulations in glycogen metabolism and the failure to influence infarct size in the ischaemic rabbit heart. Eur J Anaesthesiol 2002; 19:495-503. (Pubitemid 34787078)